Vivo Opportunity, LLC
Insider CIK 1728970 · SRRA Director, 10% owner · SLNO 10% owner · BOLT 10% owner · CRNX 10% owner · INM 10% owner · ALXO 10% owner · TERN 10% owner · IOBT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-16 | 2026-07-16 | 19 | $1.55 | $29 | 743,057 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-16 | 2026-07-16 | 2 | $1.55 | $3 | 75,019 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-15 | 2026-07-16 | 13,761 | $1.55 | $21.3K | 743,038 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-15 | 2026-07-16 | 1,389 | $1.55 | $2.2K | 75,017 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-14 | 2026-07-16 | 4,882 | $1.55 | $7.6K | 729,277 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-14 | 2026-07-16 | 493 | $1.55 | $764 | 73,628 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-02 | 2026-07-02 | 1,460 | $1.55 | $2.3K | 724,395 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-02 | 2026-07-02 | 147 | $1.55 | $228 | 73,135 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-01 | 2026-07-02 | 3,946 | $1.55 | $6.1K | 722,935 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-07-01 | 2026-07-02 | 398 | $1.55 | $617 | 72,988 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-30 | 2026-07-02 | 55 | $1.54 | $85 | 72,590 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-30 | 2026-07-02 | 545 | $1.54 | $839 | 718,989 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-08 | 2026-06-10 | 29,518 | $1.52 | $44.9K | 718,444 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-08 | 2026-06-10 | 2,982 | $1.52 | $4.5K | 72,535 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-05 | 2026-06-10 | 5,045 | $1.57 | $7.9K | 69,553 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-05 | 2026-06-10 | 49,966 | $1.57 | $78.4K | 688,926 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-04 | 2026-06-10 | 618 | $1.57 | $970 | 64,508 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-04 | 2026-06-10 | 6,125 | $1.57 | $9.6K | 638,960 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-03 | 2026-06-10 | 714 | $1.55 | $1.1K | 63,890 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-03 | 2026-06-10 | 7,069 | $1.55 | $11.0K | 632,835 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-02 | 2026-06-10 | 2,095 | $1.52 | $3.2K | 63,176 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-02 | 2026-06-10 | 20,753 | $1.52 | $31.5K | 625,766 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-01 | 2026-06-10 | 1,498 | $1.55 | $2.3K | 61,081 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-06-01 | 2026-06-10 | 14,838 | $1.55 | $23.0K | 605,013 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-29 | 2026-06-10 | 1,632 | $1.57 | $2.6K | 59,583 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-29 | 2026-06-10 | 16,164 | $1.57 | $25.4K | 590,175 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-21 | 2026-06-10 | 3,118 | $1.69 | $5.3K | 57,951 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-21 | 2026-06-10 | 30,882 | $1.69 | $52.2K | 574,011 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-20 | 2026-06-10 | 5,154 | $1.56 | $8.0K | 54,833 | SEC↗ |
| INM InMed Pharmaceuticals Inc. | P Buy | 2026-05-20 | 2026-06-10 | 51,056 | $1.56 | $79.6K | 543,129 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-28 | 2025-03-28 | 333,557 | $70.60 | $23.55M | 4,458,294 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-27 | 2025-03-28 | 1,100,000 | $67.80 | $74.58M | 4,791,851 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2025-03-26 | 2025-03-28 | 400,000 | $65.80 | $26.32M | 5,891,851 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2024-08-29 | 2024-08-29 | 100,000 | $47.22 | $4.72M | 6,291,851 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2024-08-28 | 2024-08-29 | 425,000 | $47.35 | $20.12M | 6,391,851 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2024-08-27 | 2024-08-29 | 500,000 | $48.73 | $24.36M | 6,816,851 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2024-04-30 | 2024-05-01 | 351,242 | $45.13 | $15.85M | 7,316,851 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | S Sale | 2024-04-29 | 2024-05-01 | 750,000 | $47.80 | $35.85M | 7,668,093 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-03 | 2024-04-03 | 4,149 | $6.20 | $25.7K | 268,573 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-03 | 2024-04-03 | 30,047 | $6.20 | $186.3K | 1,945,015 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-03 | 2024-04-03 | 103,870 | $6.20 | $644.0K | 4,023,741 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-02 | 2024-04-03 | 76,346 | $6.65 | $507.7K | 4,127,611 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-02 | 2024-04-03 | 3,050 | $6.65 | $20.3K | 272,722 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-02 | 2024-04-03 | 22,084 | $6.65 | $146.9K | 1,975,062 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-01 | 2024-04-03 | 136,255 | $6.99 | $952.4K | 4,203,957 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-01 | 2024-04-03 | 39,411 | $6.99 | $275.5K | 1,997,146 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | S Sale | 2024-04-01 | 2024-04-03 | 5,451 | $6.99 | $38.1K | 275,772 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 1,457 | $0.90 | $1.3K | 111,662 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 1,707 | $0.90 | $1.5K | 1,952,302 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-21 | 2023-11-22 | 236 | $0.90 | $212 | 269,587 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-20 | 2023-11-20 | 27,465 | $0.92 | $25.3K | 1,954,009 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-20 | 2023-11-20 | 3,792 | $0.92 | $3.5K | 269,823 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-20 | 2023-11-20 | 23,443 | $0.92 | $21.6K | 113,119 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 8,211 | $0.93 | $7.6K | 1,981,474 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 7,009 | $0.93 | $6.5K | 136,562 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-20 | 1,134 | $0.93 | $1.1K | 273,615 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-16 | 2023-11-20 | 6,429 | $0.96 | $6.2K | 143,571 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-16 | 2023-11-20 | 1,040 | $0.96 | $998 | 274,749 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2023-11-16 | 2023-11-20 | 7,531 | $0.96 | $7.2K | 1,989,685 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | X Exercise deriv | 2023-10-02 | 2023-10-04 | 5,215,000 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | X Exercise | 2023-10-02 | 2023-10-04 | 5,215,000 | $2.50 | $13.04M | 8,418,093 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | X Exercise deriv | 2023-09-26 | 2023-09-28 | 3,203,093 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | X Exercise | 2023-09-26 | 2023-09-28 | 3,203,093 | $1.75 | $5.61M | 3,203,093 | SEC↗ |
| IOBT IO Biotech, Inc. | P Buy deriv | 2023-08-09 | 2023-08-10 | 3,157,894 | $0.13 | $410.5K | 3,157,894 | SEC↗ |
| IOBT IO Biotech, Inc. | P Buy | 2023-08-09 | 2023-08-10 | 3,157,894 | $1.90 | $6.00M | 3,157,894 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-12-23 | 2022-12-23 | 758,620 | $7.25 | $5.50M | 4,340,212 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-09-07 | 2022-09-08 | 600,000 | $3.60 | $2.16M | 3,581,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy deriv | 2022-08-16 | 2022-08-16 | 1,500,000 | $2.42 | $3.63M | 1,500,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-16 | 2022-08-16 | 1,500,000 | $2.42 | $3.63M | 2,981,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-15 | 2022-08-16 | 1,218 | $2.99 | $3.6K | 1,481,592 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2022-08-12 | 2022-08-16 | 1,123,021 | $2.98 | $3.35M | 1,480,374 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 75,749 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 324,740 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,455,384 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 2,735,853 | $55.00 | $150.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 431,947 | $55.00 | $23.76M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 161,712 | $55.00 | $8.89M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-01-31 | 2022-01-31 | 800,000 | $27.00 | $21.60M | 2,735,853 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 1,455,384 | $13.20 | $19.21M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 324,740 | $13.20 | $4.29M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 75,749 | $13.20 | $999.9K | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 107,164 | $13.20 | $1.41M | 431,947 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 24,996 | $13.20 | $329.9K | 161,712 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 480,277 | $13.20 | $6.34M | 1,935,853 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 364,138 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 98,484 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 713,203 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 50,282 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 944,056 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 17,711 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 472,296 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,092,080 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 5,655 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 47,718 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 43,901 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 150,802 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 40,953 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 345,568 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 317,922 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 357,353 | $17.00 | $6.08M | 357,353 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 14,275 | $17.00 | $242.7K | 281,223 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 266,948 | — | $0 | 266,948 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,933,185 | — | $0 | 1,933,185 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 103,372 | $17.00 | $1.76M | 2,036,557 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 144 | $20.00 | $2.9K | 1,821,483 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 40,953 | $0.07 | $2.9K | 1,821,627 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 345,568 | — | $0 | 1,780,674 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 317,922 | — | $0 | 1,435,106 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,092,080 | — | $0 | 1,117,184 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 62 | $20.00 | $1.2K | 1,448,286 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 17,711 | $0.07 | $1.2K | 1,448,348 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 472,296 | — | $0 | 1,430,637 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 175,733 | $20.00 | $3.51M | 1,997,216 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 150,802 | — | $0 | 154,268 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 43,901 | — | $0 | 198,169 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 47,718 | — | $0 | 245,887 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 5,655 | $0.07 | $396 | 251,542 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 20 | $20.00 | $400 | 251,522 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 24,267 | $20.00 | $485.3K | 275,789 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 150,000 | $20.00 | $3.00M | 150,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 944,056 | — | $0 | 958,341 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 3,158,851 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 185,526 | $19.00 | $3.52M | 185,526 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 3,245,048 | — | $0 | 4,034,522 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 789,474 | $19.00 | $15.00M | 789,474 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 48 | $19.50 | $936 | 375,880 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 133 | $19.50 | $2.6K | 168,165 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 347 | $19.50 | $6.8K | 2,722,045 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 200 | $21.40 | $4.3K | 375,928 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 5,904 | $21.40 | $126.3K | 168,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 1,451 | $21.40 | $31.1K | 2,722,392 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 4,614 | $22.00 | $101.5K | 174,202 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 157 | $22.00 | $3.5K | 376,128 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 1,134 | $22.00 | $24.9K | 2,723,843 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 10,519 | $22.80 | $239.8K | 178,816 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 2,584 | $22.80 | $58.9K | 2,724,977 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 357 | $22.80 | $8.1K | 376,285 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 143 | $21.70 | $3.1K | 376,642 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 4,220 | $21.70 | $91.6K | 189,335 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 1,037 | $21.70 | $22.5K | 2,727,561 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 5,940 | $22.10 | $131.3K | 193,555 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 201 | $22.10 | $4.4K | 376,785 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 1,459 | $22.10 | $32.2K | 2,728,598 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 1,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 4,287 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,213 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,455,576 | — | $0 | 1,455,576 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 324,783 | — | $0 | 324,783 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 75,759 | — | $0 | 136,715 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 2,673 | $22.20 | $59.3K | 2,730,057 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 369 | $22.20 | $8.2K | 376,986 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 10,878 | $22.20 | $241.5K | 199,495 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 40,407 | $22.25 | $899.1K | 377,355 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 292,609 | $22.25 | $6.51M | 2,732,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 83,984 | $22.25 | $1.87M | 210,373 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 8,424,416 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 187,648 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 1,358,903 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 1,163,311 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 57,035 | — | $0 | 410,625 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 413,040 | — | $0 | 2,973,653 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 51,686 | $17.00 | $878.7K | 3,025,339 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 7,137 | $17.00 | $121.3K | 417,762 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 141,177 | $17.00 | $2.40M | 141,177 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 153,180 | $20.73 | $3.18M | 294,357 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 2,560,613 | — | $0 | 2,560,613 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 353,590 | — | $0 | 353,590 | SEC↗ |